Overview

GONAL-f CONSORT (Consistency in r-hFSH Starting Doses for Individualised Treatment)

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
This non-interventional study (NIS) is planned to examine the consistency of the dose recommended by the doctor for the first stimulation day with the dose recommended by the CONSORT calculator.
Details
Lead Sponsor:
Merck KGaA
Merck KGaA, Darmstadt, Germany
Treatments:
Follicle Stimulating Hormone
Hormones